WE FUND RESEARCH INTO ANY TYPE OF CANCER, ANYWHERE IN THE WORLD

WCR Website Homepage Image

WITHOUT YOUR HELP RESEARCH COULD BE LOST FOREVER.

We believe the only thing that can help beat cancer is research on a global scale. And research depends on funding. Our new TV ad, which you can watch here, brings that fact to life. Without your help, lives like Laura’s are at risk.

Please Donate

Birthday 400 X 400

Dedicate a Moment

We need you to Dedicate a Moment to someone you love to help fund game-changing research. Research that could one day deliver the promise of no life being cut short by cancer.

Dedicate a Moment

The news desk

STEM women in science day

February 11, 2016

Today, 11th February 2016, has been declared the inaugural International Day for Women and Girls in Science. A day we are embracing here at Worldwide Cancer Research as we are funding almost 50 outstanding female researchers all over the world.

Read more

Basic cancer research: aren’t we finished yet?

February 04, 2016

On World Cancer Day our CEO, Dr Helen Rippon, wrote the following piece for a cancer feature by the Independent.

Read more

More stories

Olaparib Capsule 290X290

Olaparib approved for ovarian cancer treatment

Olaparib is the first of a new class of cancer drugs called PARP inhibitors, which works by exploiting a defect some cancers have in a type of DNA repair. In December 2015, olaparib was approved for ovarian cancer treatment in the UK, and Worldwide Cancer Research played a part in its development.

Find out more